Meet our experts at ECDP!

We invite you to join our VP Sales & Marketing, Dr. Anil Berger, as speaker on this year’s Annual Meeting of the Japanese Society of Digital Pathology on Friday August 20th 2021, 15:00-16:00 JST. He will present data from our study on the robustness of our flagship AI-product BreastIHC against real-life image variability. Included were 200+ specimens balanced for clinical scores, prepared with 3 stainers, digitized on 5 scanners plus 1 microscope camera and evaluated by 10 pathologists with and without AI: Put to the test “in the wild” we show that BreastIHC works out-of-the-box in any laboratory setting.

It detects tumor cells on IHC-slides directly, then classifies them according to the relevant subgroups (per biomarker: Ki-67, ER, PR) and quantifies them in order to give the relevant clinical score(s) for each biomarker.

‍

We invite you to join our CEO, Felix Faber, as one of the Keynote Speakers at the 8th Emirates Pathology and Digital Pathology Conference online on August 11th at 10:55 a.m. BST. While we’ll miss the opportunity to meet face-to-face, we look forward to connecting digitally at 8EPUGC2021 (August 10-11 2021)! At this year’s virtual event, let us demonstrate how robust our flagship AI-product BreastIHC works with real-life image variability. It detects tumor cells on IHC-slides directly, then classifies them according to the relevant subgroups (per biomarker: Ki-67, ER, PR) and quantifies them in order to give the clinical score(s) for the respective biomarker.

Put to the test with different stainers and scanners it works out-of-the-box in any laboratory setting.